Grantham, Mayo, Van Otterloo & Co (GMO)’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Sell |
2,267
-5,854
| -72% | -$621K | ﹤0.01% | 577 |
|
|
2025
Q1 | $1.01M | Sell |
8,121
-16,994
| -68% | -$2.11M | ﹤0.01% | 457 |
|
|
2024
Q4 | $3.09M | Buy |
25,115
+22,108
| +735% | +$2.72M | 0.01% | 341 |
|
|
2024
Q3 | $335K | Sell |
3,007
-5,324
| -64% | -$593K | ﹤0.01% | 518 |
|
|
2024
Q2 | $889K | Sell |
8,331
-185,869
| -96% | -$19.8M | ﹤0.01% | 405 |
|
|
2024
Q1 | $23.4M | Sell |
194,200
-13,558
| -7% | -$1.63M | 0.09% | 169 |
|
|
2023
Q4 | $25.6M | Buy |
207,758
+25,076
| +14% | +$3.08M | 0.11% | 139 |
|
|
2023
Q3 | $23.6M | Sell |
182,682
-1,295
| -0.7% | -$168K | 0.11% | 159 |
|
|
2023
Q2 | $22.8M | Sell |
183,977
-44,723
| -20% | -$5.54M | 0.11% | 169 |
|
|
2023
Q1 | $33.5M | Sell |
228,700
-2,900
| -1% | -$424K | 0.17% | 124 |
|
|
2022
Q4 | $36.9M | Buy |
231,600
+29,600
| +15% | +$4.72M | 0.2% | 106 |
|
|
2022
Q3 | $26.9M | Buy |
202,000
+5,100
| +3% | +$680K | 0.16% | 132 |
|
|
2022
Q2 | $30.7M | Sell |
196,900
-4,800
| -2% | -$749K | 0.17% | 119 |
|
|
2022
Q1 | $31.4M | Buy |
201,700
+22,100
| +12% | +$3.44M | 0.15% | 121 |
|
|
2021
Q4 | $22.9M | Buy |
179,600
+3,100
| +2% | +$395K | 0.11% | 153 |
|
|
2021
Q3 | $23M | Buy |
176,500
+28,600
| +19% | +$3.72M | 0.11% | 148 |
|
|
2021
Q2 | $26.3M | Buy |
147,900
+30,100
| +26% | +$5.35M | 0.13% | 134 |
|
|
2021
Q1 | $19.4M | Buy |
117,800
+27,600
| +31% | +$4.54M | 0.11% | 154 |
|
|
2020
Q4 | $14.9M | Buy |
+90,200
| New | +$14.9M | 0.09% | 147 |
|